St. Jude Children's Research Hospital
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
Remote Exercise Video Adaptations to Maximize Physical Activity in Childhood Cancer
- Conditions
- SurvivorshipChildhood CancerFrailty
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06411704
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Conditions
- T-cell LymphomaT-cell Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia
- Interventions
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06390319
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
School Readiness Intervention for Preschool Children With Sickle Cell Disease
- Conditions
- Sickle Cell Disease
- Interventions
- Device: The adapted Kids in Transition to School InterventionDevice: Standard school resources
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT06367192
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- Conditions
- ALL, ChildhoodMDSAML, ChildhoodHematologic MalignancyLymphoma
- Interventions
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06326463
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- Conditions
- Lymphoblastic LymphomaMixed Phenotype Acute LeukemiaAcute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 850
- Registration Number
- NCT06289673
- Locations
- 🇺🇸
United States, Tennessee St. Jude Children's Research Hospital, Memphis, Tennessee, United States
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Conditions
- Atypical FibroxanthomaMyoepitheliomaFibrosarcoma NOSMyxofibrosarcomaOsteosarcoma, ExtraskeletalAdipocytic NeoplasmLiposarcomaAngiomatoid Fibrous HistiocytomaAngiosarcoma
- Interventions
- Procedure: Surgical resectionRadiation: Proton beam radiation therapy
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 139
- Registration Number
- NCT06239272
- Locations
- 🇺🇸
Washington University Medical Center, Saint Louis, Missouri, United States
🇺🇸Our Lady of the Lake Children's Hospital, Baton Rouge, Louisiana, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Parents Reflecting On Hope During Hospice Through Photovoice
- Conditions
- Bereavement
- First Posted Date
- 2024-01-02
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT06187636
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Conditions
- Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaAcute Leukemia of Ambiguous Lineage
- Interventions
- Drug: intrathecal (IT) chemotherapy
- First Posted Date
- 2023-12-20
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06177067
- Locations
- 🇺🇸
Children's Mercy Hospital of Kansas City, Kansas City, Missouri, United States
🇺🇸Memorial Sloan- Kettering Cancer Center, New York, New York, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Conditions
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06098430
- Locations
- 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors
- Conditions
- Childhood CancerLeukemiaLymphoma
- Interventions
- Device: Headspace
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06053268
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States